AMR Clinical Norman is now enrolling healthy adults ages 60 and older for an investigational Respiratory Syncytial Virus (RSV) vaccine study.
Qualified participants:
Have not received a previous RSV vaccine
Have not been diagnosed with RSV in the past 4 months
Have not experienced any severe side effects or allergic reactions to any vaccine
Meet other study criteria
Qualified participants will receive all study-related care and investigational vaccine at no cost. Compensation is available up to $750.00 for study-related time and travel.
If you're interested in learning more about this trial, you can reach out to AMR Clinical Norman today by calling 405-703-5263 or visiting their website at www.amrnorman.com for more detailed information.